G. D. Cummings

1.1k total citations
11 papers, 674 citations indexed

About

G. D. Cummings is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, G. D. Cummings has authored 11 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in G. D. Cummings's work include Hepatitis B Virus Studies (2 papers), Transgenic Plants and Applications (2 papers) and Lung Cancer Treatments and Mutations (1 paper). G. D. Cummings is often cited by papers focused on Hepatitis B Virus Studies (2 papers), Transgenic Plants and Applications (2 papers) and Lung Cancer Treatments and Mutations (1 paper). G. D. Cummings collaborates with scholars based in United States. G. D. Cummings's co-authors include Robert H. Goldstein, Raissa Lerner, Marcus Zervos, Lawrence R. Crane, Donald P. Levine, David A. Decker, Arnold Herskovic, Milton G. Mutchnick, Muhyi Al‐Sarraf and John F. Ensley and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cancer.

In The Last Decade

G. D. Cummings

11 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. D. Cummings United States 10 239 152 136 114 102 11 674
M. J. Phillips United Kingdom 16 149 0.6× 83 0.5× 114 0.8× 111 1.0× 69 0.7× 36 720
Dolores Subirá Spain 15 178 0.7× 160 1.1× 116 0.9× 105 0.9× 201 2.0× 40 860
Emanuela Ricotti Italy 14 156 0.7× 98 0.6× 116 0.9× 95 0.8× 26 0.3× 22 681
H. Claeys Belgium 17 272 1.1× 144 0.9× 142 1.0× 274 2.4× 42 0.4× 25 1.0k
Colette Chapuis‐Cellier France 15 111 0.5× 41 0.3× 157 1.2× 98 0.9× 48 0.5× 40 604
Shingo Tanaka Japan 19 160 0.7× 207 1.4× 125 0.9× 70 0.6× 29 0.3× 68 904
E. Dybkjær Denmark 13 215 0.9× 41 0.3× 100 0.7× 99 0.9× 57 0.6× 42 845
John R. Neefe United States 18 248 1.0× 208 1.4× 281 2.1× 98 0.9× 50 0.5× 51 888
Bernadette Rain France 9 445 1.9× 245 1.6× 130 1.0× 263 2.3× 79 0.8× 10 910
Maria Augusta Cipriano Portugal 15 243 1.0× 180 1.2× 171 1.3× 213 1.9× 30 0.3× 73 866

Countries citing papers authored by G. D. Cummings

Since Specialization
Citations

This map shows the geographic impact of G. D. Cummings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. D. Cummings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. D. Cummings more than expected).

Fields of papers citing papers by G. D. Cummings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. D. Cummings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. D. Cummings. The network helps show where G. D. Cummings may publish in the future.

Co-authorship network of co-authors of G. D. Cummings

This figure shows the co-authorship network connecting the top 25 collaborators of G. D. Cummings. A scholar is included among the top collaborators of G. D. Cummings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. D. Cummings. G. D. Cummings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mutchnick, Milton G., Karen L. Lindsay, Eugene R. Schiff, et al.. (1999). Thymosin α1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double‐blind and placebo‐controlled study. Journal of Viral Hepatitis. 6(5). 397–403. 48 indexed citations
2.
Upadhyay, Jyoti, Bijan Shekarriz, Jeffrey A. Nemeth, et al.. (1999). Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.. PubMed. 5(12). 4105–10. 76 indexed citations
3.
4.
Cummings, G. D., et al.. (1992). Serum levels of immunoreactive thymosin alpha 1 and thymosin beta 4 in large cohorts of healthy adults.. PubMed. 19(1). 45–52. 22 indexed citations
5.
Mutchnick, Milton G., Henry D. Appelman, Hau-Tim Chung, et al.. (1991). Thymosin treatment of chronic hepatitis B: A placebo-controlled pilot trial. Hepatology. 14(3). 409–415. 114 indexed citations
6.
Tapazoglou, Efstathios, et al.. (1991). The Incidence and significance of thromboembolic complications in patients with high-grade gliomas. Cancer. 68(12). 2621–2624. 64 indexed citations
7.
Crane, Lawrence R., Donald P. Levine, Marcus Zervos, & G. D. Cummings. (1986). Bacteremia in Narcotic Addicts at the Detroit Medical Center. I. Microbiology, Epidemiology, Risk Factors, and Empiric Therapy. Clinical Infectious Diseases. 8(3). 364–373. 96 indexed citations
9.
Decker, David A., et al.. (1984). Brain metastases in patients with renal cell carcinoma: prognosis and treatment.. Journal of Clinical Oncology. 2(3). 169–173. 92 indexed citations
10.
Samal, Bohumil A., Samuel Brooks, G. D. Cummings, et al.. (1980). Estrogen receptors and responsiveness of advanced breast cancer to chemotherapy. Cancer. 46(S12). 2925–2927. 12 indexed citations
11.
Lerner, Raissa, Robert H. Goldstein, & G. D. Cummings. (1971). Stimulation of Human Leukocyte Thromboplastic Activity by Endotoxin. Experimental Biology and Medicine. 138(1). 145–148. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026